Company news
Lensar, Inc. (NASDAQ:LNSR) news
Lensar, Inc. news releases on 6ix. Latest, Aug 13, 2026: LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
Press releases & updates
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
August 13, 2026
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
May 8, 2026
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
April 30, 2026
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
March 30, 2026
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
March 16, 2026
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
March 15, 2026
LENSAR® Provides Update on Pending Acquisition by Alcon
February 24, 2026
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update
November 6, 2025
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 2, 2025
LENSAR Reports Second Quarter 2025 Results and Provides Business Update
August 7, 2025
LENSAR Reports First Quarter 2025 Results and Provides Business Update
May 8, 2025
Alcon Agrees to Acquire LENSAR, Inc.
March 23, 2025
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
February 27, 2025
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
February 18, 2025
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day
November 25, 2024
LENSAR Reports Third Quarter 2024 Results and Provides Business Update
November 6, 2024
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
October 30, 2024
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems
October 7, 2024
LENSAR to Participate in Two Upcoming Investor Conferences
September 3, 2024
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
August 7, 2024
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
August 6, 2024
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 31, 2024
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
May 22, 2024
LENSAR Reports First Quarter 2024 Results and Provides Business Update
May 8, 2024
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 1, 2024
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
March 3, 2024
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
February 25, 2024
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
November 8, 2023
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
November 1, 2023
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
August 8, 2023
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
August 1, 2023
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
July 23, 2023
LENSAR Reports First Quarter 2023 Results and Provides Business Update
May 14, 2023
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
May 9, 2023
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 15, 2023
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
March 8, 2023
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
February 13, 2023
LENSAR to Present at Two Upcoming Investor Conferences
November 21, 2022
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
November 8, 2022
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
November 1, 2022
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
September 7, 2022
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
August 15, 2022
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
August 7, 2022
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
July 31, 2022
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
June 12, 2022
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
May 8, 2022
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
May 1, 2022
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 2, 2022
LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY
February 28, 2022
LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
February 27, 2022